skip to main content

Bisphosphonate Dosing — SCE Rheumatology MCQ

Instant feedback + full explanation. One question, done properly.

HardMetabolic Bone DiseaseBisphosphonate DosingSCE Rheumatology

A patient taking oral alendronate develops dysphagia and retrosternal pain. What is the most appropriate next step?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: BStop the oral bisphosphonate and assess for oesophageal injury

New dysphagia or retrosternal pain may indicate bisphosphonate oesophagitis. Oral treatment should be withheld and the patient assessed. Administration requires plain water, remaining upright and avoiding food or other medicines for the specified interval.

Reference: https://www.nice.org.uk/guidance/conditions-and-diseases/musculoskeletal-conditions